Gh Research Plc logo

Gh Research Plc Share Price Today

(NASDAQ: GHRS)

Gh Research Plc share price is $16.32 & ₹1,421.39 as on 5 Feb 2025, 2.30 'hrs' IST

$16.32

-1.67

(-9.31%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Gh Research Plc share price in Dollar and Rupees. Guide to invest in Gh Research Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gh Research Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Gh Research Plc share price movements

  • Today's Low: $13.96
    Today's High: $18.71

    Day's Volatility :25.4%

  • 52 Weeks Low: $6.00
    52 Weeks High: $20.50

    52 Weeks Volatility :70.73%

Gh Research Plc (GHRS) Returns

PeriodGh Research PlcSector (Health Care)Index (Russel 2000)
3 Months
106.31%
0.5%
0.0%
6 Months
68.29%
-2.3%
0.0%
1 Year
135.78%
3.8%
0.0%
3 Years
-5.42%
11.4%
-11.7%

Gh Research Plc (GHRS) Key Statistics

in dollars & INR

Previous Close
$17.99
Open
$19.19
Today's High
$18.7142
Today's Low
$13.96
Market Capitalization
$551.5M
Today's Volume
$10.3M
52 Week High
$20.5
52 Week Low
$6.0
Revenue TTM
$0.0
EBITDA
$-45.5M
Earnings Per Share (EPS)
$-0.79
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-16.2%

How to invest in Gh Research Plc Stock (GHRS) from India?

It is very easy for Indian residents to invest directly in Gh Research Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gh Research Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gh Research Plc or GHRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gh Research Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gh Research Plc shares which would translate to 0.053 fractional shares of Gh Research Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gh Research Plc, in just a few clicks!

Returns in Gh Research Plc (GHRS) for Indian investors in Rupees

The Gh Research Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gh Research Plc investment value today

Current value as on today

₹2,18,757

Returns

₹1,18,757

(+118.76%)

Returns from Gh Research Plc Stock

₹1,13,893 (+113.89%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Gh Research Plc (GHRS)

-35%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Gh Research Plc Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gh Research Plc

  • Bvf Inc

    19.99%

  • RA Capital Management, LLC

    12.85%

  • RTW INVESTMENTS, LLC

    6.39%

  • FMR Inc

    5.28%

  • Verition Fund Managegment, LLC

    2.03%

  • Cormorant Asset Management, LLC

    1.14%

Analyst Recommendation on Gh Research Plc

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Gh Research Plc(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gh Research Plc Stock (GHRS)

What analysts predicted

Upside of 91.48%

Target:

$31.25

Current:

$16.32

Insights on Gh Research Plc Stock (Ticker Symbol: GHRS)

  • Price Movement

    In the last 7 days, GHRS stock has moved up by 89.4%
  • GHRS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 87.4%

Gh Research Plc Technicals Summary

Sell

Neutral

Buy

Gh Research Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Gh Research Plc (GHRS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gh Research Plc logo
99.89%
68.29%
135.78%
-5.42%
-7.97%
Biontech Se logo
-0.32%
51.19%
24.81%
-30.66%
288.02%
Regeneron Pharmaceuticals, Inc. logo
-6.9%
-37.55%
-28.89%
7.15%
74.63%
Vertex Pharmaceuticals Incorporated logo
16.87%
0.96%
13.03%
93.36%
95.94%
Alnylam Pharmaceuticals, Inc. logo
17.76%
5.53%
59.46%
84.7%
118.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gh Research Plc logo
NA
NA
NA
-0.8
-0.16
-0.13
NA
4.21
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.64
16.64
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gh Research Plc logo
Buy
$551.5M
-7.97%
NA
0.0%
Biontech Se logo
Buy
$29.7B
288.02%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.0B
74.63%
16.64
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.9B
95.94%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.0B
118.8%
NA
-15.86%

About Gh Research Plc

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). The company's lead program is GH001, an inhalable mebufotenin product candidate, currently under Phase 2b clinical trial for the treatment of patients with TRD, as well as Phase 2a clinical trials for the treatment of Bipolar II disorder and postpartum depression. It is also involved in the development of GH002, an intravenous mebufotenin product candidate for IV administration, currently under Phase 1 clinical trials for the treatment of psychiatric or neurological disorder; and GH003, an intranasal mebufotenin product candidate for nasal administration, which is currently in preclinical development with a focus on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Organization
Gh Research Plc
Employees
49
CEO
Mr. Florian Schonharting M.Sc. (Econ)
Industry
Services

Management People of Gh Research Plc

NameTitle
Mr. Florian Schonharting M.Sc. (Econ)
Co-Founder & Non-Executive Chairman of the Board
Dr. Velichka Valcheva M.D.
Chief Executive Officer
Mr. Magnus Halle
Co-Founder & MD of Ireland
Ms. Julie Ryan F.C.A.
Vice President of Finance
Mr. Aaron Cameron M.B.A.
Chief Operating Officer

Important FAQs about investing in GHRS Stock from India :

What is Gh Research Plc share price today?

Gh Research Plc share price today stands at $16.32, Open: $19.19 ; Previous Close: $17.99 ; High: $18.71 ; Low: $13.96 ; 52 Week High: $20.50 ; 52 Week Low: $6.00.

The stock opens at $19.19, after a previous close of $17.99. The stock reached a daily high of $18.71 and a low of $13.96, with a 52-week high of $20.50 and a 52-week low of $6.00.

Can Indians buy Gh Research Plc shares?

Yes, Indians can invest in the Gh Research Plc (GHRS) from India.

With INDmoney, you can buy Gh Research Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gh Research Plc at zero transaction cost.

How can I buy Gh Research Plc shares from India?

It is very easy to buy Gh Research Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gh Research Plc (GHRS) be purchased?

Yes, you can buy fractional shares of Gh Research Plc with INDmoney app.

What are the documents required to start investing in Gh Research Plc stocks?

To start investing in Gh Research Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gh Research Plc Stock (GHRS)?

Today’s highest price of Gh Research Plc (GHRS) is $18.71.

Today’s lowest price of Gh Research Plc (GHRS) is $13.96.

What is today's market capitalisation of Gh Research Plc?

Today's market capitalisation of Gh Research Plc GHRS is 551.5M

What is the 52 Week High and Low Range of Gh Research Plc Stock (GHRS)?

  • 52 Week High

    $20.50

  • 52 Week Low

    $6.00

What are the historical returns of Gh Research Plc (GHRS)?

  • 1 Month Returns

    99.89%

  • 3 Months Returns

    68.29%

  • 1 Year Returns

    135.78%

  • 5 Years Returns

    -7.97%

Who is the Chief Executive Officer (CEO) of Gh Research Plc ?

Mr. Florian Schonharting M.Sc. (Econ) is the current Chief Executive Officer (CEO) of Gh Research Plc.